Revvity Inc. logo

Revvity Inc. (RVTY)

Market Open
17 Jun, 19:05
NYSE NYSE
$
94. 02
-2.33
-2.42%
$
11.02B Market Cap
- P/E Ratio
0.28% Div Yield
47,123 Volume
- Eps
$ 96.35
Previous Close
Day Range
94 95.78
Year Range
87.7 129.5
Earnings results expected in 41 days

Summary

RVTY trading today lower at $94.02, a decrease of 2.42% from yesterday's close, completing a monthly decrease of -0.92% or $0.87. Over the past 12 months, RVTY stock lost -16.37%.
RVTY pays dividends to its shareholders, with the most recent payment made on May 09, 2025. The next estimated payment will be in In 1 month on Aug 09, 2025 for a total of $0.07.
The last earnings report, released on Apr 28, 2025, exceeded the consensus estimates by 0%. On average, the company has surpassed earnings expectations by 0.06%, based on the last three reports. The next scheduled earnings report is due on Jul 28, 2025.
Revvity Inc. has completed 4 stock splits, with the recent split occurring on Jun 04, 2001.
The company's stock is traded on 6 different exchanges and in various currencies, with the primary listing on NYSE (USD).
Want to track RVTY and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!

RVTY Chart

RVTY Stock Falls Despite the Latest Launch of Automated Instrument

RVTY Stock Falls Despite the Latest Launch of Automated Instrument

Revvity unveils IDS i20, a fully automated immunodiagnostics platform designed to enhance lab efficiency and expand specialty testing.

Zacks | 3 weeks ago
RVTY Rises as Q1 Earnings & Sales Beat Estimates, '25 Sales View Up

RVTY Rises as Q1 Earnings & Sales Beat Estimates, '25 Sales View Up

Revvity's first-quarter results showcase strong growth in Diagnostics business, along with recovery in Life Sciences segmental sales.

Zacks | 1 month ago
Revvity, Inc. (RVTY) Q1 2025 Earnings Call Transcript

Revvity, Inc. (RVTY) Q1 2025 Earnings Call Transcript

Revvity, Inc. (NYSE:RVTY ) Q1 2025 Earnings Conference Call April 28, 2025 8:00 AM ET Company Participants Steve Willoughby - Senior Vice President, Investor Relations Prahlad Singh - President & Chief Executive Officer Max Krakowiak - Senior Vice President & Chief Financial Officer Conference Call Participants Patrick Donnelly - Citi Dan Brennan - TD Cowen Matt Sykes - Goldman Sachs Vijay Kumar - Evercore ISI Catherine Schulte - Baird Daniel Arias - Stifel Dan Leonard - UBS Luke Sergott - Barclays Tycho Peterson - Jefferies Operator Welcome everyone to Q1 2025 Revvity Earnings Conference Call. My name is Sammy, and I will be coordinating your call today.

Seekingalpha | 1 month ago

Revvity Inc. (RVTY) FAQ

What is the stock price today?

The current price is $94.02.

On which exchange is it traded?

Revvity Inc. is listed on NYSE.

What is its stock symbol?

The ticker symbol is RVTY.

Does it pay dividends? What is the current yield?

It does not pay dividends to its shareholders.

What is its market cap?

As of today, the market cap is 11.02B.

What is the earnings per share?

The EPS is 0.

When is the next earnings date?

The next earnings report will release on Jul 28, 2025.

Has Revvity Inc. ever had a stock split?

Revvity Inc. had 4 splits and the recent split was on Jun 04, 2001.

Revvity Inc. Profile

Medical - Diagnostics & Research Industry
Healthcare Sector
Dr. Prahlad R. Singh Ph.D. CEO
NYSE Exchange
714046109 Cusip
US Country
11,000 Employees
- Last Dividend
4 Jun 2001 Last Split
- IPO Date

Overview

Revvity, Inc., previously known as PerkinElmer, Inc., marks a significant name in the health sciences industry, offering comprehensive solutions, technologies, and services across the globe, including the Americas, Europe, Asia, and other international territories. With its inception in 1937 and headquarters in Waltham, Massachusetts, Revvity has grown to serve an expansive range of clients, including pharmaceutical and biotechnology companies, laboratories, academic and research institutions, public health authorities, private healthcare organizations, doctors, and government agencies. Operating through two main segments - Life Sciences and Diagnostics - Revvity, Inc. brings forward a suite of instruments, reagents, informatics, software, and much more, catering to a wide array of testing, screening, and research needs in the health sciences sector.

Products and Services

Revvity, Inc.'s product portfolio and services are vast, covering various needs within the life sciences and diagnostics fields. Here's an overview of their most notable offerings:

  • AutoDELFIA, BACS-on-Beads, BIOCHIPs, and similar products: These are used for the testing and screening of genetic abnormalities, disorders, and diseases. They serve a critical role in early detection and screening processes for conditions such as down syndrome, hypothyroidism, muscular dystrophy, infertility, and various metabolic conditions.
  • chemagic, Chitas, DELFIA, DELFIA Xpress, and related instruments: These instruments and technologies are essential for genomic workflows, supporting applications in oncology, immunodiagnostics, drug discovery, and more. They provide the necessary tools for researchers and healthcare practitioners to analyze and understand genetic material and protein interactions.
  • JANUS, LabChip, LifeCycle, LimsLink, and similar software and systems: Key in informatics and laboratory management, these software solutions and systems optimize the operations within laboratories, improving efficiency, data management, and processing in research and diagnostic settings.
  • Migele, MultiPROBE, NEXTFLEX, NextPrep, and other reagents and assay platforms: These products are designed for specific applications within the fields of diagnostics and life sciences research, including DNA sequencing, protein analysis, and more. They are integral to the processes of detecting, analyzing, and understanding complex biological materials.
  • T-SPOT, Twister, VariSpec, ViaCord, VICTOR 2D, Zephyr, and more brand names: Under these brand names, Revvity, Inc. offers a diverse range of products that cater to different aspects of health sciences, from diagnostic tests for infectious diseases to advanced instruments for genetic and proteomic research. Each brand specializes in a unique area of the health sciences, providing specialized tools and technologies to their respective fields.

Contact Information

Address: 940 Winter Street
Phone: 781 663 6900